Eyenovia Inc (NAS:EYEN)
$ 0.7652 -0.0048 (-0.62%) Market Cap: 41.22 Mil Enterprise Value: 50.14 Mil PE Ratio: 0 PB Ratio: 19.13 GF Score: 21/100

Eyenovia Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript

Jul 14, 2021 / 01:00PM GMT
Release Date Price: $4.71 (+0.21%)
Matthew Kaplan
Ladenburg Thalmann & Co. Inc. - Analyst

Hi, good morning. It's my pleasure to introduce our next presenting company, Eyenovia. Presenting for the Company is Dr. Sean Ianchulev, CEO, and also joining us is John Gandolfo, the CFO. Sean, I'll give the platform to you and hopefully we'll have some time for some Q&A towards the end of the presentation. But thanks for joining us today at the second day of our conference, Sean.

Sean Ianchulev
Eyenovia, Inc. - CEO, CMO, Director

Thank you, Matt, and thank you for all of your insightful reviews through the years. And this is a great opportunity to update everybody who knows the story and also to introduce what we are doing here at Eyenovia because it's a very timely presentation given all of the recent milestones and some of the upcoming events that we have.

Eyenovia is a specialty biopharmaceutical company in the ophthalmic space, which has a proprietary delivery system for topical delivery to the eye called the Optejet, on the basis of which we are building a next-generation of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot